GSK plc (GSK)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 6 |
| Ownership rank: | 112 |
| % of all portfolios: | 0.079% |
| Hold Price * : | $52.42 |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
| ≡ |
Hillman Capital Management |
3.51 |
Reduce 5.18% |
92,383 |
4,843,000 |
| ≡ |
Dodge & Cox Funds |
1.32 |
Reduce 17.84% |
48,197,514 |
2,526,514,000 |
| ≡ |
Kahn Brothers Group |
1.31 |
Reduce 1.58% |
158,438 |
8,305,000 |
| ≡ |
Tweedy Browne |
0.32 |
Reduce 0.32% |
81,527 |
4,274,000 |
| ≡ |
Sarah Ketterer - Causeway Capital Management |
0.00 |
Reduce 35.53% |
7,163 |
375,000 |
| ≡ |
Richard Pzena - Pzena Investment Management |
0.00 |
Add 30.20% |
24,507 |
1,285,000 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock